No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ABBV240628C180000
- 0.26
- +0.25+2500.00%
15min DelayClose Jun 28 15:49 ET
0.26High0.01Low
0.01Open0.01Pre Close9 Volume189 Open Interest180.00Strike Price34.00Turnover606.85%IV5.10%PremiumJun 28, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.26Extrinsic Value100Contract SizeAmericanOptions Type0.0921Delta0.0269Gamma659.69Leverage Ratio-38.9800Theta0.0000Rho60.77Eff Leverage0.0017Vega
Intraday
- 5D
- Daily
News
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
AbbVie, Genmab Blood Cancer Therapy Endorsed in EU
AbbVie (ABBV.US) has reached a $250 million acquisition agreement and obtained a potential first-in-class therapy.
Recently, AbbVie (ABBV.US) announced the acquisition of Celsius Therapeutics for a total consideration of USD 250 million.
AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
AbbVie Completes Acquisition of Celsius Therapeutics for $250m
Comments
$Genmab(GMAB.US$ $AbbVie(ABBV.US$
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)
3
$Chevron(CVX.US$
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
32
3
From YouTube
6
Interesting both for the (1) shift in the macro-trend to M&A (vs. Licensing) and (2) change in top spenders
$Merck & Co(MRK.US$ $Bristol-Myers Squibb(BMY.US$ $Johnson & Johnson(JNJ.US$ $Pfizer(PFE.US$ $Novo-Nordisk A/S(NVO.US$ $AbbVie(ABBV.US$
$Merck & Co(MRK.US$ $Bristol-Myers Squibb(BMY.US$ $Johnson & Johnson(JNJ.US$ $Pfizer(PFE.US$ $Novo-Nordisk A/S(NVO.US$ $AbbVie(ABBV.US$
10
1
Read more